The International Society for Vaccines

NextGen December Webinar
2025-12-04
Title: Microcapsules for single-shot vaccination
Speaker: Romain Guyon, PhD, University of Oxford, UK

Title: From Dopamine to Vaccine – or: What is it that you do at work, son?
Speaker: Stefan Jungbluth, PhD, MBA, European Vaccine Initiative, Germany

Moderator: Allegra Peletta, PhD,Vaccine Formulation Institute, Switzerland

Time:
US & Europe: 07:00 (PST) | 10:00 (EDT) 15:00 (GMT) | 16:00 (CET)
South America: 09:00 (CST) | 12:00 (ART)
Africa: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)
Asia: 20:30 (IST) | 23:00 (CST) | 00:00 (KST)
Australia: 23:00 (AWST) | 01:00 (AEST) +1 | 02:00 (AEDT) +1

Join the webinar here

NextGen November Webinar
2025-11-13
Title: All about microneedle vaccination and the journey of building a vaccine startup
Speaker: Dr. Koen van der Maaden, Leiden University, the Netherlands

Title: Navigating transitions between academia and industry, and tips for securing fellowships
Speaker: Dr. Kevin M. Koo, The University of Queensland Centre for Clinical Research (UQCCR), Australia

Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd

Time:
US & Europe: 01:00 (PST) | 04:00 (EDT) 09:00 (GMT) | 10:00 (CET)
South America: 03:00 (CST) | 06:00 (ART)
Africa: 10:00 (West Africa) | 11:00 (South Africa) | 12:00 (East Africa)
Asia: 14:30 (IST) | 17:00 (CST) | 18:00 (KST)
Australia: 17:00 (AWST) | 19:00 (AEST) | 20:00 (AEDT)

Join the webinar here

Visit ISV's YouTube Channel
2025-11-07 09:51 UTC

2025 ISV Annual Congress
2025-10-28 - 2025-10-30 | Protea Hotel, Stellenbosch, South Africa
2025 ISV Annual Congress Website here
Register here.

NextGen October webinar
2025-10-02
TITLE: COVID-19-related inflammation of the placenta impedes fetal development in pregnant hamsters
Speaker: Yana Kumpaneko, MD, KU Leuven, Belgium

TITLE: Building a Positive Research Culture
Speaker: Prof. Dr. Adrian Liston, University of Cambridge, United Kingdom

Time Zones:

America & Europe: 07:00 (PDT) |10:00 (EDT) | 15:00 (BST) | 16:00 (CEST)

Central & South America: 08:00 (Mexico) |11:00 (Argentina)
Africa: 15:00 (West Africa) | 16:00 (South Africa) | 17:00 (East Africa)

Asia & Australia: 19:30 (IST) | 22:00 (CST) | 23:00 midnight (KST) | 22:00 (AWST) | 00:00 (+1 AEST) 3 October

Join the webinar: https://zoom.us/j/91697440883

ISV's Influenza Mini-Symposium
2025-09-25
PRESENTERS

09:00 – 09:30 (EDT)
Development of universal flu vaccines – induction of cross reactive T cells
Guus Rimmelzwaan , M.D., Ph.D
Professor, TIHO Hannover

09:30 – 10:00 (EDT)
Leveraging the Power of AAV for Influenza Vaccines
Stacey Schultz-Cherry, Ph.D
Member, Department of Host-Microbe Interactions
St Jude Children’s Research Hospital Memphis

10:00 – 10:30 (EDT)
FluMist Self/Caregiver Administration @ Home
Allyn Bandell, Ph.D
US Medical Affairs, Lead – Influenza AstraZeneca

10:30 – 11:00 (EDT)
CD388: A Novel Long-Acting Antiviral for Pre-Exposure Prophylaxis Against Influenza
Tim Alefantis, Ph.D
Vice President, Influenza Strategy, Cidara

TIME ZONES
US & Europe: 06:00 (PDT) / 09:00 (EDT) 14:00 (BST) / 15:00 (CEST)
South America: 10:00 (Argentina) / 07:00 (Mexico)
Africa: 14:00 (West Africa) / 15:00 (South Africa) / 16:00 (East Africa)
Asia: 18:30 (IST) / 21:00 (CST) / 22:00 (KST)
Australia: 21:00 (AWST) / 23:00 (AEST) / 23:00 (AEDT)

Zoom Link: https://zoom.us/j/93155639420

Next Generation Vaccinologists September Webinar
2025-09-04
Title: What could possibly go wrong? Lessons learned the hard way from not thinking about IP early

Speaker: Dr. Belinda Hartmann, Uniquest Pty Ltd

Title: Developing vaccines using the molecular clamp technology

Speaker:Dr. Andrew Young, The University of Queensland, Australia

Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd

Time Zones:

America & Europe: 01:00 (PDT) |04:00 (EDT) | 09:00 (BST) | 10:00 (CEST)
Central & South America: 02:00 (Mexico) |05:00 (Argentina)
Africa: 09:00 (West Africa) | 10:00 (South Africa) | 11:00 (East Africa)
Asia & Australia: 13:30 (IST) | 16:00 (CST) | 17:00 (KST) | 16:00 (AWST) | 18:00 (AEST)

Join the webinar here: zoom.us/j/93291034519

Speeding up vaccine design and antibody discovery using cryoEM and AI/ML
2025-08-27
Title:Speeding up vaccine design and antibody discovery using cryoEM and AI/ML

Speaker: Andrew Ward, Scripps Research, United States

MODERATOR: Camila Coelho, Icahn School of Medicine at Mount Sinai

Time Zones:

America & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST)

Central & South America: 09:00 (Mexico) |12:00 noon (Argentina)
Africa: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)

Asia & Australia: 20:30 (IST) | 23:00 (CST) | 00:00 midnight (KST) | 23:00 (AWST) | 01:00 (AEST) 28 August

Join the webinar: https://zoom.us/j/99951071640

Next Generation Vaccinologists August Webinar
2025-08-07
Title: Mapping B Cell Precursors in HIV: A Southern African Perspective on Germline-Targeting Vaccine Strategies

Speaker: Dr. Judie Magura, Africa Health Research Institute (AHRI), South Africa

Title: Being resourceful in an under-resourced research landscape: leveraging optimism and collaboration; Focus: foot and mouth disease virus (FMDV)

Speaker: Dr. Keba Lebani, Botswana International University of Science and Technology, Botswana

Moderator: Dr. Sandra Depelsenaire, Vaxxas Pty Ltd

Time Zones:

America & Europe: 01:00 (PDT) |04:00 (EDT) | 09:00 (BST) | 10:00 (CEST)
Central & South America: 02:00 (Mexico) |05:00 (Argentina)
Africa: 09:00 (West Africa) | 10:00 (South Africa) | 11:00 (East Africa)
Asia & Australia: 13:30 (IST) | 16:00 (CST) | 17:00 (KST) | 16:00 (AWST) | 18:00 (AEST)

Join the webinar here

Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform
2025-07-29
Title: Development and Clinical Study in Multiple Phase 1 and 2 trials of infectious disease and cancer vaccines based on the MVA platform
Speaker: Don Diamond, City of Hope, United States

Time Zones:

America & Europe: 08:00 (PDT) |11:00 (EDT) | 16:00 (BST) | 17:00 (CEST)
Central & South America: 09:00 (Mexico) |12:00 noon (Argentina)
Africa: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)
Asia & Australia: 20:30 (IST) | 23:00 (CST) | 00:00 midnight (KST) | 23:00 (AWST) | 01:00 (AEST) 30 July

Join the webinar: www.zoom.us/j/91080572379 ​​

Next Generation Vaccinologists July Webinar
2025-07-10
Title: Bench to the City
Speaker: Dr. Ravi Degun, Ernst Young – Parthenon

Title: From Pipettes to Pitches: Navigating a Career in Nanomedicine
Speaker: Dr. Martin Rabel, Cytiva

Time:
US & Europe: 07:00 (PDT) | 10:00 (EDT) 15:00 (BST) | 16:00 (CEST)
South America: 11:00 (Argentina) | 08:00 (Mexico)
Africa: 15:00 (West Africa) | 16:00 (South Africa) | 17:00 (East Africa)
Asia: 19:30 (IST) | 22:00 (CST) | 23:00 (KST)
Australia: 22:00 (AWST) | 00:00 (+1, AEDT)

Join the webinar here

Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use
2025-07-01
Title: Estimating the impact of vaccines in reducing antimicrobial resistance and antibiotic use.
Speaker: Mateusz Hasso-Agopsowicz, World Health Organization, Switzerland

Time Zones:

America & Europe: 06:00 (PDT) |09:00 (EDT) | 14:00 (BST) | 15:00 (CEST)
Central & South America: 07:00 (Mexico) |10:00 (Argentina)
Africa: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)
Asia & Australia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST) | 21:00 (AWST) | 23:00 (AEST)

Join the webinar here

HIV Vaccines
2025-06-26
Speakers, Presentation Title, and Bio’s:

TITLE: Why HIV Vaccines Are Still Needed
SPEAKER: Glenda Gray, South African Medical Research Council

Glenda Gray, MBBCH, FCPaeds (SA), DSc (honoris causa, Simon Fraser University 2013), DSc (honoris causa, Stellenbosch University 2018), Honorary Doctorate in Law (Rhodes University, 2019), an NRF A rated scientist, was the first female president and CEO of the South African Medical Research Council (SAMRC) and is currently the Chief Scientific Officer at the SAMRC.
Gray trained as a medical doctor and pediatrician at the University of the Witwatersrand and co-founded and led the internationally renowned Perinatal HIV Research Unit based at the Chris Hani Baragwanath Hospital in Soweto. As a clinical researcher, she is internationally known for her research in HIV vaccines and interventions to prevent mother to child transmission of HIV. She is the Co-PI of the of the NIH funded HIV Vaccine Trials Network and is responsible for the expansion of HIV vaccine research in Africa. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1.
She is a member of the Academy of Science in South Africa, the African Academy of Science and The World Academy of Sciences (TWAS). She is one of a handful of foreign associates of the USA National Academy of Medicine, of the National Academies of Science, and has served on their Global Health Board. She was the Chair for the Global Alliance for Chronic Diseases (GACD). Gray has also been awarded the IAPAC “Hero of Medicine” award for work done in the field of HIV treatment in children and adults.

TITLE: Clinical Progress Toward Vaccine Induction of HIV Broadly Neutralizing Antibodies
SPEAKER: William Schief, Moderna

William Schief is Vice President, Protein Design, Moderna; Professor, Immunology and Microbiology, Scripps Research; and Executive Director, Vaccine Design, IAVI Neutralizing Antibody Center at Scripps. He has a BS in Applied Mathematics from Yale University and a PhD in Physics from the University of Washington. His work focuses on computation-guided and structure-based design of vaccines and therapeutics for a wide range of diseases. For HIV vaccine development, the topic of this ISV 2025 mini-symposium, Dr. Schief is pursuing the strategy of germline-targeting vaccine design with many collaborators. This strategy aims to induce broadly neutralizing antibodies (bnAbs) through a series of vaccinations that first activates naïve bnAb-precursor B cells sharing key genetic features of bnAbs and then guides B cell somatic hypermutation and affinity maturation to produce bnAbs in germinal center and memory B cells, plasma cells, and serum.

TITLE: Immune Correlates of Protection for HIV Vaccines
SPEAKER: Peter Gilbert, Fred Hutch Cancer Center

Dr. Peter Gilbert, Professor of Biostatistics at the Fred Hutchinson Cancer Center and the University of Washington, conducts statistical science research for randomized trials of candidate vaccines for HIV, SARS-CoV-2, and other infectious pathogens. He specializes in statistical methods for analyzing these trials in pursuit of understanding “immune correlates of protection,” which involve immune response biomarkers as well as genotypic and immunophenotypic pathogen features. A central application of this research is development of biomarker surrogate endpoints that can be used to infer the level of vaccine efficacy against infectious disease outcomes. Dr. Gilbert is a Principal Investigator of the Statistical Data Management Center for the NIH NIAID-sponsored HIV Vaccine Trials Network.

TITLE: The Progress of Polyvalent DNA Prime and Protein Boost HIV Vaccine (PDPHV)
SPEAKER: Shan Lu,UMASS Chan Medical School and Worcester HIV Vaccine (WHV)

Shan Lu is a Professor Emeritus in the Department of Medicine, University of Massachusetts Medical School, USA. He was a pioneer in nucleic acid vaccines in the early 1990s and has continuously worked to advance this field in the past three decades. He advocated the heterologous prime-boost vaccination concept and developed the world’s first polyvalent DNA prime protein boost HIV vaccine into human clinical studies, which showed robust and broadly cross-reactive immune responses.
Besides being a US board-certified physician in internal medicine with more than 20 years’ clinical practice, Dr. Lu has managed major NIH-funded vaccine development programs, including GMP manufacturing, FDA IND filing and human clinical studies. He has broad biotech industry collaborations, and joined Worcester HIV Vaccine in 2022, serving as its Chief Scientific Officer. He was the past president of International Society for Vaccines (ISV) and is the current co-chair of Corporate Partnership Program (CPP) at the International AIDS Society (IAS).

Moderators Bio’s:

MODERATOR: Lindsey Baden, Brigham and Women’s Hospital
Lindsey Baden, MD, serves as vice president of Clinical Research for Brigham and Women’s Hospital. In his role as vice president, Baden provides comprehensive oversight of clinical research at the Brigham and is responsible for developing and implementing operational strategies, as well as building and maintaining the necessary infrastructure and resources in support of our clinical research mission and operational goals. He also oversees the Center for Clinical Investigation, serves as the primary liaison with Harvard Catalyst/Harvard Medical School, and has responsibility for increasing and maintaining research relationships across the Brigham, Mass General Brigham and our local collaborators.
Baden, an infectious diseases specialist, joined the Brigham in 1995 and has served in several critical leadership roles, including directing the Infectious Diseases Immunocompromised Host program at the Brigham and Dana-Farber, acting as program leader for the Clinical Research Centers of Harvard Catalyst and directing the Center for Clinical Investigation. A professor at Harvard Medical School and deputy editor of The New England Journal of Medicine, Baden is a highly respected clinician and clinical investigator. He has received continuous funding from the National Institutes of Health (NIH) throughout his career and is an expert in developing new therapeutics and vaccines. In response to the COVID-19 crisis, he was integral in the design and conduct of the pivotal NIH co-sponsored vaccine efficacy trials, Of note, he is the co-principal investigator for the phase 3 COVE study, which evaluated the mRNA-1273 (Moderna) vaccine candidate against COVID-19. This phase three trial, conducted in part at the Brigham, has led to the unprecedented rapid emergency use authorization, subsequent licensure and broad global use of this highly effective vaccine.

MODERATOR: Nyaradzo Mgodi, University of Zimbabwe Clinical Trials Research Center

Nyaradzo Mavis Mgodi is a clinical pathologist with over 10 years of experience conducting HIV clinical trials in women of reproductive age in Africa. She is lead investigator in multiple clinical trials assessing various biomedical HIV prevention interventions, like vaginal rings, oral PrEP, injectable PrEP and broadly neutralizing antibodies. Nyaradzo serves as a member of the HPTN Executive Committee and a scientific reviewer for the Medical Research Council of Zimbabwe and has served as a technical advisor for the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) survey. She is a member of the Policy and Implementation Steering Committee for the Global Evaluation of Microbicide Sensitivity (GEMS) project. She served as a Programme Organizing Committee member for HIVR4P 2018 and Conference Advisory Committee member for the International AIDS Society in 2017.

Time Zones:

America & Europe: 06:00 (PDT) |09:00 (EDT) | 14:00 (BST) | 15:00 (CEST)
Central & South America: 07:00 (Mexico) |10:00 (Argentina)
Africa: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)
Asia & Australia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST) | 21:00 (AWST) | 23:00 (AEST)

Join the webinar here

NextGen June Webinar
2025-06-12
Title: CTH522/CAF®01-induced Th17 T cells contribute to protection against infection with Chlamydia trachomatis
Speaker: Dr. Nina Nguyen, Statens Serum Institut

Title: Vaccine adjuvants, delivery systems and immunostimulators
Speaker: Dr. Dennis Christensen, Statens Serum Institut

Time:
US & Europe: 07:00 (PDT) | 10:00 (EDT) 15:00 (BST) | 16:00 (CEST)
South America: 08:00 (Mexico) | 11:00 (Argentina)
Africa: 15:00 (West Africa) | 16:00 (South Africa) | 17:00 (East Africa)
Asia: 19:30 (IST) | 22:00 (CST) | 23:00 (KST)
Australia: 22:00 (AWST) | 00:00 (+1, AEST)

Join the webinar here

Computational Modelling of Vaccine Responses
2025-05-28 11:00 - 12:00 (America/New_York)
SPEAKER

Computational Modelling of Vaccine Responses
Tal Einav, LaJolla Institute of Immunology, United States

Time:
US & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (BST) | 17:00 (CEST)
South America: 12:00 (Argentina) | 09:00 (Mexico)
Africa: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)
Asia: 20:30 (IST) | 23:00 (CST) | 24:00 (KST)
Australia: 23:00 (AWST) | 01:00 (AEST) – 29 May | 22:00 (AEDT) – 29 May

Join the webinar here

Vaccines and Therapies for Chronic Viral Diseases
2025-05-21 - 2025-05-22

Next Generation Vaccinologists May 2025 Webinar
2025-05-08
SPEAKERS:
Delivering Pandemic Vaccines in 100 Days — What Will It Take?, Dr Renske Hesselink, CEPI

Advancing saRNA Delivery: Evaluating Novel PEI-Inspired Polymers as Non-Viral Carriers, Lisa Opsomer, PhD student, Ghent University

Time:
Thursday, May 8th
US & Europe: 08:00 (PDT) | 11:00 (EDT) 16:00 (BST) | 17:00 (CEST)
South America: 12:00 (Argentina) | 10:00 (Mexico)
Africa: 16:00 (West Africa) | 17:00 (South Africa) | 18:00 (East Africa)
Asia: 20:30 (IST) | 23:00 (CST) | 24:00 (KST)
Australia: 23:00 (AWST) | 01:00 (AEST) – 9 May | 22:00 (AEDT) – 9 May

Join the webinar here

Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
2025-04-30 11:00 - 17:00 UTC
Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
P.J. (Paul) Wichgers Schreur, Wageningen Bioveterinary Research, Netherlands

Time:
US & Europe: 08:00 (PDT) | 11:00 (EDT) | 16:00 (BST) |17:00 (CEST)
South America: 12:00 noon (Argentina) | 10:00 (Mexico)
Africa: 04:00 (West Africa) | 05:00 (South Africa) | 06:00 (East Africa)
Asia: 08:30 (IST) | 11:00 (CST) | 12:00 (KST)
Australia: 23:00 (AWST) | 01:00 (AEST) 1 May | 20:00 1 May (AEDT)

Join the webinar here

RSV Vaccines
2025-04-24
SPEAKERS:

Global Lifelong Burden of RSV – Louis Bont, M.D., Ph.D, Professor, University Medical Center Utrecht

Prefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV – Peter Kwong, Ph.D, Richard J. Stock Professor, Biochemistry and Molecular Biophysics Columbia University

PIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children, Hong Jin, Ph.D, Chief Scientific Officer, CynVac/Blue Lake Bio

RSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years – Kumar Ilangovan, MD, MSPH, MMCi, FACP, FAAP, Director, Vaccines Clinical Research & Global Clinical Lead, RSV Adult Vaccine Program, Pfizer Vaccine

Time:
US & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)
South America: 10:00 (Argentina) | 07:00 (Mexico)
Africa: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)
Asia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)
Australia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT)

Join the webinar here

NextGen April Webinar
2025-04-10 01:00 - 14:00 UTC
Title: Connecting Ideas with Impact: Building Effective Academia-Industry Alliances
Speaker: Dr Balaji Somasundaram, Denteric Pty Ltd

Title: From bench to business development,
Speaker: Dr Wasan Forsyth, Vaxxas Pty Ltd

Time:
US & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)
South America: 10:00 (Argentina) | 07:00 (Mexico)
Africa: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)
Asia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)
Australia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT)

Join the webinar here

Needle free vaccination using a simple to apply skin patch: clinical and manufacturing progress
2025-03-28 03:00 (America/New_York)
Speaker: Angus Forster, Vaxxas, Australia

Time: 04:00-05:00am EDT
Join the webinar here

Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
2025-03-06
Title: Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Speaker: Nicholas Tursi, University of Pennsylvania Perelman School of Medicine

Title: Exploring Galsomes, adjuvanted mRNA-LNPs, for the development of more effective vaccines against Mycobacterium tuberculosis
Ilke Aernout, Ghent University

Time: 10:00 EST
Join the webinar here

RESCHEDULED - Emerging Avian Infections and Vaccines
2025-02-28 03:00 (America/New_York)
Webinar Rescheduled to February 28th, 2025
Title: Emerging Avian Infections and Vaccines,
Speaker: Hualan Chen, Harbin Veterinary Research Institute, China
Time: 3:00-4:00 EST
Join the webinar here

Longitudinal Assessment of Human Immune Responses to Commercial Influenza Vaccination
2025-02-07 10:00 - 23:00 (America/New_York)

Pneumococcal Vaccines
2025-01-30 09:00 - 11:00 (America/New_York)
Recording is available here.
